Immunomodulation in Cutaneous T Cell Lymphoma

Primary Cutaneous B-Cell Lymphomas in Patients With Impaired Immunity

“…The absence of the indolent forms of CBCL (PCMZL and PCFCCL) in this group of patients indicates that the development of these subtypes is probably hampered by immunosuppressive regimen. An analogous disproportion between aggressive and indolent forms of primary cutaneous lymphoma in immunocompromised patients, has been previously discussed in PTLD of T-cell origin (30).…”